N-[1-[2-(hydroxymethyl)pyrrolidin-1-yl]-1-oxo-3-phenylpropan-2-yl]-2-(2-oxo-2-piperidin-1-ylethyl)heptanamide

C28H43N3O4 — CID 20779383

IUPACN-[1-[2-(hydroxymethyl)pyrrolidin-1-yl]-1-oxo-3-phenylpropan-2-yl]-2-(2-oxo-2-piperidin-1-ylethyl)heptanamide
SMILESCCCCCC(CC(=O)N1CCCCC1)C(=O)NC(Cc1ccccc1)C(=O)N1CCCC1CO
InChIInChI=1S/C28H43N3O4/c1-2-3-6-14-23(20-26(33)30-16-9-5-10-17-30)27(34)29-25(19-22-12-7-4-8-13-22)28(35)31-18-11-15-24(31)21-32/h4,7-8,12-13,23-25,32H,2-3,5-6,9-11,14-21H2,1H3,(H,29,34)
InChIKeyBCATVTOQRCPVQR-UHFFFAOYSA-N
MW485.67 g/mol
LogP3.30
Rot. Bonds12

About N-[1-[2-(hydroxymethyl)pyrrolidin-1-yl]-1-oxo-3-phenylpropan-2-yl]-2-(2-oxo-2-piperidin-1-ylethyl)heptanamide

N-[1-[2-(hydroxymethyl)pyrrolidin-1-yl]-1-oxo-3-phenylpropan-2-yl]-2-(2-oxo-2-piperidin-1-ylethyl)heptanamide (PubChem CID 20779383) has the molecular formula C28H43N3O4 and a molecular weight of 485.67 g/mol. Its IUPAC name is N-[1-[2-(hydroxymethyl)pyrrolidin-1-yl]-1-oxo-3-phenylpropan-2-yl]-2-(2-oxo-2-piperidin-1-ylethyl)heptanamide.

Molecular Properties

Compound NameN-[1-[2-(hydroxymethyl)pyrrolidin-1-yl]-1-oxo-3-phenylpropan-2-yl]-2-(2-oxo-2-piperidin-1-ylethyl)heptanamide
PubChem CID20779383
Molecular FormulaC28H43N3O4
Molecular Weight485.67 g/mol
Exact Mass485.33
IUPAC NameN-[1-[2-(hydroxymethyl)pyrrolidin-1-yl]-1-oxo-3-phenylpropan-2-yl]-2-(2-oxo-2-piperidin-1-ylethyl)heptanamide
SMILESCCCCCC(CC(=O)N1CCCCC1)C(=O)NC(Cc1ccccc1)C(=O)N1CCCC1CO
InChIInChI=1S/C28H43N3O4/c1-2-3-6-14-23(20-26(33)30-16-9-5-10-17-30)27(34)29-25(19-22-12-7-4-8-13-22)28(35)31-18-11-15-24(31)21-32/h4,7-8,12-13,23-25,32H,2-3,5-6,9-11,14-21H2,1H3,(H,29,34)
InChIKeyBCATVTOQRCPVQR-UHFFFAOYSA-N
XLogP3.30
TPSA89.95 Ų
H-Bond Donors2
H-Bond Acceptors4
Rotatable Bonds12
Heavy Atoms35
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500485.67
LogP ≤ 53.30
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 104

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze N-[1-[2-(hydroxymethyl)pyrrolidin-1-yl]-1-oxo-3-phenylpropan-2-yl]-2-(2-oxo-2-piperidin-1-ylethyl)heptanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[1-[2-(hydroxymethyl)pyrrolidin-1-yl]-1-oxo-3-phenylpropan-2-yl]-2-(2-oxo-2-piperidin-1-ylethyl)heptanamide?
The IUPAC name of N-[1-[2-(hydroxymethyl)pyrrolidin-1-yl]-1-oxo-3-phenylpropan-2-yl]-2-(2-oxo-2-piperidin-1-ylethyl)heptanamide (CID 20779383) is N-[1-[2-(hydroxymethyl)pyrrolidin-1-yl]-1-oxo-3-phenylpropan-2-yl]-2-(2-oxo-2-piperidin-1-ylethyl)heptanamide.
What is the SMILES notation for N-[1-[2-(hydroxymethyl)pyrrolidin-1-yl]-1-oxo-3-phenylpropan-2-yl]-2-(2-oxo-2-piperidin-1-ylethyl)heptanamide?
The canonical SMILES for N-[1-[2-(hydroxymethyl)pyrrolidin-1-yl]-1-oxo-3-phenylpropan-2-yl]-2-(2-oxo-2-piperidin-1-ylethyl)heptanamide is CCCCCC(CC(=O)N1CCCCC1)C(=O)NC(Cc1ccccc1)C(=O)N1CCCC1CO.
What is the InChIKey of N-[1-[2-(hydroxymethyl)pyrrolidin-1-yl]-1-oxo-3-phenylpropan-2-yl]-2-(2-oxo-2-piperidin-1-ylethyl)heptanamide?
The InChIKey is BCATVTOQRCPVQR-UHFFFAOYSA-N. The full InChI is InChI=1S/C28H43N3O4/c1-2-3-6-14-23(20-26(33)30-16-9-5-10-17-30)27(34)29-25(19-22-12-7-4-8-13-22)28(35)31-18-11-15-24(31)21-32/h4,7-8,12-13,23-25,32H,2-3,5-6,9-11,14-21H2,1H3,(H,29,34).
What are the key properties of N-[1-[2-(hydroxymethyl)pyrrolidin-1-yl]-1-oxo-3-phenylpropan-2-yl]-2-(2-oxo-2-piperidin-1-ylethyl)heptanamide?
N-[1-[2-(hydroxymethyl)pyrrolidin-1-yl]-1-oxo-3-phenylpropan-2-yl]-2-(2-oxo-2-piperidin-1-ylethyl)heptanamide has a molecular weight of 485.67 g/mol, XLogP of 3.30, 12 rotatable bonds, 2 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for N-[1-[2-(hydroxymethyl)pyrrolidin-1-yl]-1-oxo-3-phenylpropan-2-yl]-2-(2-oxo-2-piperidin-1-ylethyl)heptanamide is sourced from PubChem (CID 20779383), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).